How has been the historical performance of Torrent Pharma?

Answer:The historical performance of Torrent Pharma shows a consistent growth trajectory in net sales and profits over the years. Breakdown: Torrent Pharma's net sales have steadily increased from INR 7,673.00 crore in March 2019 to INR 11,516.00 crore in March 2025, reflecting a strong upward trend. The total operating income followed a similar pattern, rising from INR 7,673.00 crore in March 2019 to INR 11,516.00 crore in March 2025. The operating profit (PBDIT) also demonstrated growth, increasing from INR 2,041.00 crore in March 2019 to INR 3,744.00 crore in March 2025, with an operating profit margin that improved from 26.59% to 32.88% during the same period. Profit before tax rose from INR 562.00 crore in March 2019 to INR 2,673.00 crore in March 2025, while profit after tax reached INR 1,911.00 crore in March 2025, up from INR 436.00 crore in March 2019. The company's total assets increased from INR 13,576.53 crore in March 2020 to INR 14,395.59 crore in March 2025, although total liabilities decreased from INR 14,505.45 crore in March 2024 to INR 14,395.59 crore in March 2025. Cash flow from operating activities peaked at INR 3,266.00 crore in March 2024 but fell to INR 2,585.00 crore in March 2025, while net cash outflow was recorded at INR -261.00 crore in March 2025. Overall, Torrent Pharma's financial metrics indicate a robust growth trajectory with increasing revenues and profits, despite some fluctuations in cash flow.